1. Home
  2. QNCX vs SWVL Comparison

QNCX vs SWVL Comparison

Compare QNCX & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • SWVL
  • Stock Information
  • Founded
  • QNCX 2012
  • SWVL 2017
  • Country
  • QNCX United States
  • SWVL United Arab Emirates
  • Employees
  • QNCX N/A
  • SWVL N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • SWVL Business Services
  • Sector
  • QNCX Health Care
  • SWVL Consumer Discretionary
  • Exchange
  • QNCX Nasdaq
  • SWVL Nasdaq
  • Market Cap
  • QNCX 44.0M
  • SWVL 50.6M
  • IPO Year
  • QNCX 2019
  • SWVL N/A
  • Fundamental
  • Price
  • QNCX $1.02
  • SWVL $3.10
  • Analyst Decision
  • QNCX Strong Buy
  • SWVL
  • Analyst Count
  • QNCX 5
  • SWVL 0
  • Target Price
  • QNCX $8.00
  • SWVL N/A
  • AVG Volume (30 Days)
  • QNCX 138.1K
  • SWVL 24.8K
  • Earning Date
  • QNCX 05-12-2025
  • SWVL 04-29-2025
  • Dividend Yield
  • QNCX N/A
  • SWVL N/A
  • EPS Growth
  • QNCX N/A
  • SWVL N/A
  • EPS
  • QNCX N/A
  • SWVL N/A
  • Revenue
  • QNCX N/A
  • SWVL $17,207,362.00
  • Revenue This Year
  • QNCX N/A
  • SWVL N/A
  • Revenue Next Year
  • QNCX N/A
  • SWVL N/A
  • P/E Ratio
  • QNCX N/A
  • SWVL N/A
  • Revenue Growth
  • QNCX N/A
  • SWVL N/A
  • 52 Week Low
  • QNCX $0.51
  • SWVL $2.40
  • 52 Week High
  • QNCX $2.45
  • SWVL $15.41
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 26.91
  • SWVL 36.54
  • Support Level
  • QNCX $0.93
  • SWVL $2.81
  • Resistance Level
  • QNCX $1.26
  • SWVL $3.25
  • Average True Range (ATR)
  • QNCX 0.10
  • SWVL 0.44
  • MACD
  • QNCX -0.03
  • SWVL -0.06
  • Stochastic Oscillator
  • QNCX 18.03
  • SWVL 31.95

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About SWVL Swvl Holdings Corp

Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. Its technology and services provide commuters, travelers and businesses with an alternative to traditional public transportation, taxi companies or other ridesharing companies. The company's core product is B2C Swvl Retail offering, which provides riders with a network of minibuses and other vehicles running on fixed or semi-fixed routes within cities. Commuters use its Swvl mobile application to book rides between pre-defined pick-up points located throughout the city.

Share on Social Networks: